These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11267473)

  • 41. Tacrolimus monotherapy following alemtuzumab induction in combined kidney-pancreas transplantation: results of a prospective randomized trial.
    Bösmüller C; Ollinger R; Sieb M; Weissenbacher A; Schneeberger S; Pratschke J; Margreiter R
    Ann Transplant; 2012 Dec; 17(4):45-51. PubMed ID: 23274323
    [TBL] [Abstract][Full Text] [Related]  

  • 42. FK 506 induction and rescue therapy in pancreas transplant recipients.
    Stratta RJ; Taylor RJ; Castaldo P; Sindhi R; Sudan D; Weide LG; Frisbie K; Cushing KA; Jerius J; Radio SJ
    Transplant Proc; 1996 Apr; 28(2):991-2. PubMed ID: 8623492
    [No Abstract]   [Full Text] [Related]  

  • 43. Tacrolimus in kidney transplantation. A clinical review.
    Kliem V; Brunkhorst R
    Nephron; 1998; 79(1):8-20. PubMed ID: 9609456
    [No Abstract]   [Full Text] [Related]  

  • 44. Steroid withdrawal or steroid avoidance in renal transplant recipients: focus on tacrolimus-based immunosuppressive regimens.
    Krämer BK; Krüger B; Mack M; Obed A; Banas B; Paczek L; Schlitt HJ
    Transplant Proc; 2005 May; 37(4):1789-91. PubMed ID: 15919467
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low incidence of rejection after synchronous pancreas-kidney transplantation with Neoral.
    Cattral MS; Hemming AW; Greig PD; Rowsell C; Chari R; Wright E; Donat D; Cole E; Levy GA
    Transplant Proc; 1998 Aug; 30(5):1946. PubMed ID: 9723346
    [No Abstract]   [Full Text] [Related]  

  • 46. Randomized, prospective trial of mycophenolate mofetil versus azathioprine for prevention of acute renal allograft rejection after simultaneous kidney-pancreas transplantation.
    Merion RM; Henry ML; Melzer JS; Sollinger HW; Sutherland DE; Taylor RJ
    Transplantation; 2000 Jul; 70(1):105-11. PubMed ID: 10919583
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combining FK 506 and mycophenolate mofetil for the treatment of acute corticosteroid-resistant rejection following kidney transplantation: a new therapeutic concept.
    Carl S; Dörsam J; Mandelbaum A; Staehler G; Wiesel M
    Transplant Proc; 1998 Jun; 30(4):1236-7. PubMed ID: 9636502
    [No Abstract]   [Full Text] [Related]  

  • 48. Daclizumab induction, tacrolimus, mycophenolate mofetil and steroids as an immunosuppression regimen for primary kidney transplant recipients.
    Ciancio G; Burke GW; Suzart K; Roth D; Kupin W; Rosen A; Olson L; Esquenazi V; Miller J
    Transplantation; 2002 Apr; 73(7):1100-6. PubMed ID: 11965039
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tacrolimus versus cyclosporine in primary simultaneous pancreas-kidney transplantation: preliminary results at 1 year of a large multicenter trial.
    Land W; Malaise J; Sandberg J; Langrehr J;
    Transplant Proc; 2002 Aug; 34(5):1911-2. PubMed ID: 12176625
    [No Abstract]   [Full Text] [Related]  

  • 50. Simultaneous kidney-pancreas transplantation without antilymphocyte induction.
    Reddy KS; Stratta RJ; Shokouh-Amiri H; Alloway R; Somerville T; Egidi MF; Gaber LW; Gaber AO
    Transplantation; 2000 Jan; 69(1):49-54. PubMed ID: 10653379
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cadaveric renal transplantation against a positive historic crossmatch under tacrolimus immunosuppression: long-term follow-up.
    Lyne JC; Vivas CA; Shapiro R; Scantlebury VP; Hakala TR; Starzl TE; Jordan ML
    Transplant Proc; 1997; 29(1-2):312. PubMed ID: 9123015
    [No Abstract]   [Full Text] [Related]  

  • 52. Humanized, nonmitogenic OKT3 antibody, huOKT3 gamma(Ala-Ala): initial clinical experience.
    Woodle ES; Bluestone JA; Zivin RA; Jolliffe LK; Auger J; Xu D; Thistlethwaite JR
    Transplant Proc; 1998 Jun; 30(4):1369-70. PubMed ID: 9636555
    [No Abstract]   [Full Text] [Related]  

  • 53. Risk and benefit of antibody induction therapy in combination with tacrolimus immunosuppression after liver transplantation.
    Klupp J; Bechstein WO; Pratschke J; Tullius SG; Gebhard A; Lobeck H; Langrehr JM; Neuhaus R; Neuhaus P
    Transplant Proc; 1998 Jun; 30(4):1443-4. PubMed ID: 9636585
    [No Abstract]   [Full Text] [Related]  

  • 54. Outcome after steroid withdrawal in adult renal transplant patients receiving tacrolimus-based immunosuppression.
    Chakrabarti P; Wong HY; Toyofuku A; Scantlebury VP; Jordan ML; Vivas C; Jain AB; McCauley J; Johnston J; Randhawa PS; Hakala TR; Simmons RL; Fung JJ; Starzl TE; Shapiro R
    Transplant Proc; 2001; 33(1-2):1235-6. PubMed ID: 11267274
    [No Abstract]   [Full Text] [Related]  

  • 55. Sirolimus in late acute OKT3-resistant and/or steroid-resistant rejection after simultaneous pancreas and kidney transplantation.
    Kahl A; Oppert M; Müller A; Settmacher U; Lepenies J; Klupp J; Kampf D; Neuhaus P; Frei U
    Transplant Proc; 2002 Sep; 34(6):2253-5. PubMed ID: 12270387
    [No Abstract]   [Full Text] [Related]  

  • 56. Thymoglobulin versus basiliximab induction therapy for simultaneous kidney-pancreas transplantation: impact on rejection, graft function, and long-term outcome.
    Bazerbachi F; Selzner M; Boehnert MU; Marquez MA; Norgate A; McGilvray ID; Schiff J; Cattral MS
    Transplantation; 2011 Nov; 92(9):1039-43. PubMed ID: 22002345
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tacrolimus, mycophenolate mofetil and corticosteroids as primary immunosuppression after renal transplantation at the Hospital 12 de Octubre, Madrid.
    Morales JM; Andrés A; Morales E; Herrero JC; Cubas A; Praga M; Hernández E; Ortuño T; Dominguez-Gil B; Carreño A; Delgado M; Manzanares C
    Transplant Proc; 1999 Nov; 31(7A):75S-77S. PubMed ID: 10576051
    [No Abstract]   [Full Text] [Related]  

  • 58. Tacrolimus (FK506) and mycophenolate mofetil combination therapy versus tacrolimus in adult liver transplantation.
    Eckhoff DE; McGuire BM; Frenette LR; Contreras JL; Hudson SL; Bynon JS
    Transplantation; 1998 Jan; 65(2):180-7. PubMed ID: 9458011
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antilymphocyte induction is no longer necessary in simultaneous pancreas and kidney transplantation.
    Rigotti P; Baldan N; Cadrobbi R; Furian L; Sarzo G; Dall'Olmo L; Ancona E
    Transplant Proc; 2002 Aug; 34(5):1906-8. PubMed ID: 12176623
    [No Abstract]   [Full Text] [Related]  

  • 60. Mycophenolate mofetil in pancreas transplantation.
    Gruessner RW; Sutherland DE; Drangstveit MB; Wrenshall L; Humar A; Gruessner AC
    Transplantation; 1998 Aug; 66(3):318-23. PubMed ID: 9721799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.